Scott Jensen Email & Phone Number

Indianapolis, Indiana Area

►►► Direct Reports: 14 | P&L: $750M | Global Bandwidth: 75+ Countries across 6 Continents | 600+ Clinical Trials Delivered | Lead Multicultural Teams In: Asia/Pacific, Europe, Latin America, North America, & ROWI received multiple vertical promotions due to significant contributions to global growth and profitability. In this capacity, I directed all aspects of the global operational strategy with a strong focus on R&D operational processes. My responsibilities span the globe, with my biggest challenge (and success) being a call to improve efficiency across the organization and hasten clinical trial delivery globally. DELIVERED RESULTS: ☑ I optimized our business strategy and created a dynamic KPI dashboard to drive results☑ I slashed the cycle time 33% and synergized key services while driving critical trial execution for over 600 projects – surpassing expectations.☑ I trailblazed a global monitoring program with incredible impact on inspection and audit results – taking the company to new heights for quality and excellence.

►►► Direct & Indirect Reports: 30 | IT Infrastructure Launch | Set Cost Structure for 129 New Studies | Facilitated 3800+ Budget/Contract Negotiations | Managed 665 Specialty Contracts Annually | Managed Payment Systems & ProcessesI envisioned and led the next-gen transformation of Lilly’s R&D business standards and oversight processes impacting operations in 50 countries. While defining and administering high-impact policies and processes, I radically improved cycle time, cost structure, and regulatory infrastructure while setting/championing a bold new mission. Obtaining buy-in at all levels, I guided my team in strategic planning/budgeting, and collaborated with multifunctional teams to identify areas for improvement and close the gaps. I clarified core values, heightened organizational excellence, shared best practices, and greatly improved operations across the board.DELIVERED RESULTS:☑ Reduced global cost structure 23%+ and cycle time 20%. ☑ Spearheaded global transparency program development for U.S., Europe, and Japan at the height of regulatory changes. Proactively developed strategies to address evolution of the government’s role in pharmaceuticals. ☑ Fortified compliance strategies and shielded company from risk by taking swift action to comply with changing regulations, including Sarbanes-Oxley compliance requirements. ☑ Rolled out robust IT infrastructure with risk-reporting capabilities. Other roles:Founder / Manager, US Clinical Contracts and Grants OfficeController, US Medical DivisionVarious Leadership PositionsMultiple Command Positions, 82nd Airborne Division, US Army, Fort Bragg, NC

Master Of Business Administration (M.B.A.), Management And Finance

1984, Bachelor Of Science In Business Administration